Ecolab Inc.

(New York Stock Exchange)
Slightly Bullish +15

Ecolab (ECL) Q3 Earnings Meet Estimates

📈 Ecolab reported Q3 earnings of $2.18 per share, matching analyst consensus estimates after non-recurring adjustments.

💰 Quarterly revenue reached $4.69 billion, beating expectations by 0.49% and growing year-over-year to $4.17 billion.

📊 The company has topped consensus revenue estimates four times over the last four consecutive quarters.

📉 Ecolab shares have underperformed the S&P 500 this year, gaining 10.1% versus the index's 12.1% return.

⚠️ The stock currently holds a Zacks Rank #4 (Sell) due to unfavorable earnings estimate revisions trends.

🔮 Analysts project $2.20 EPS and $4.73 billion revenue for the upcoming quarter based on current consensus.

🏭 Ecolab operates within the Chemical - Specialty industry, which is currently ranked in the bottom 33% of all Zacks industries.

Bullish Signals
  • Ecolab delivered Q3 earnings of $2.18 per share, matching analyst consensus estimates after adjusting for non-recurring items.
  • The company posted quarterly revenue of $4.69 billion, surpassing the Zacks Consensus Estimate by 0.49%.
  • Ecolab has topped consensus revenue estimates four times over the last four quarters, demonstrating consistent performance.
  • Year-over-year earnings increased from $2.07 per share to $2.18 per share, reflecting solid organic growth.
Risk Factors
  • Ecolab shares have underperformed the S&P 500 this year, rising only 10.1% compared to the index's 12.1% gain.
  • The stock currently holds a Zacks Rank #4 (Sell) due to unfavorable earnings estimate revisions trends prior to the report.
Full Analysis
Ecolab (ECL) reported third-quarter earnings of $2.18 per share, which matched the Zacks Consensus Estimate after adjusting for non-recurring items. This represents an increase from $2.07 per share a year ago. Revenue for the quarter ended September 2026 reached $4.69 billion, surpassing analyst expectations by 0.49% and exceeding the prior year's revenue of $4.17 billion. The company has demonstrated consistent performance against consensus estimates, topping revenue projections four times over the last four quarters and beating earnings estimates twice during that same period. Despite these solid operational results, Ecolab shares have underperformed the broader market this year, rising approximately 10.1% compared to the S&P 500's gain of 12.1%. Analyst sentiment remains cautious ahead of future earnings releases, with the stock currently holding a Zacks Rank #4 (Sell) due to unfavorable estimate revisions trends prior to this report. The consensus outlook for the coming quarter projects $2.20 in EPS and $4.73 billion in revenue, while the full-year fiscal year estimates stand at $8.16 per share and $17.96 billion in total revenue. Investors are advised to monitor management commentary on the earnings call for further guidance, as the sustainability of the stock's price movement will largely depend on future expectations. The broader Chemical - Specialty industry is currently ranked in the bottom 33% of all Zacks industries, which historically correlates with underperformance relative to the top half of the sector.